Phase II Investigation of 99mTc-rBitistatin for Imaging Venous Thrombosis

Status Withdrawn

Clinical Trial Summary

99mTc-rBitistatin is a radiolabeled polypeptide which is designed to stick to blood clots so that the blood clots can be detected by imaging. The purpose of this trial is to evaluate in patients the safety of 99mTc-rBitistatin and its ability to locate blood clots in the arms and legs.

Clinical Trial Description

n/a

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00808626
Study type	Interventional
Source	Temple University
Contact
Status	Withdrawn
Phase	Phase 1/Phase 2
Start date	December 2008
Completion date	March 2017

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02567903` - Tourniquet Study: A Clinical Trial Into the Effect of Tourniquet Use on the Coagulation System	N/A
Completed	`NCT02247414` - Warfarin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy and Azygoportal Disconnection	Phase 4
Recruiting	`NCT02650453` - Ongoing Registry of Deep Venous Reconstructions	N/A
Completed	`NCT00839657` - Clarification of Optimal Anticoagulation Through Genetics	Phase 3
Completed	`NCT02065388` - Pharmacogenetic Dosing of Warfarin	Phase 3
Terminated	`NCT00872079` - Personalized Warfarin Dosing by Genomics and Computational Intelligence	N/A
Terminated	`NCT00521885` - Comparison of Arixtra vs. Lovenox to Prevent Blood Clots in Medically Ill Patients	N/A
Completed	`NCT02892565` - Hypercoagulable Phenotype by Thrombinography (in Presence of C Protein Dynamic Inhibitory System)	N/A
Completed	`NCT00346424` - Safety and Efficacy Study of Alfimeprase in Subjects With Occluded Central Catheters	Phase 3
Active, not recruiting	`NCT04349189` - Venous Thrombosis Biomarkers in Sickle Cell Disease and Sickle Cell Trait
Recruiting	`NCT02238444` - Warfarin Prevents Portal Vein Thrombosis in Liver Cirrhotic Patients With Hypersplenism After Laparoscopic Splenectomy	Phase 4
Recruiting	`NCT02597218` - Incidence of Venous Thromboembolic Disease and Portal Vein Thrombosis After Hepatectomy. A Cohort Study.
Completed	`NCT00986154` - Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study).	Phase 3
Completed	`NCT00246025` - A Study of BIBR 1048 in Prevention of Venous Thromboembolism in Patients With TKR Surgery.	Phase 2
Completed	`NCT00097357` - BMS-562247 in Subjects Undergoing Elective Total Knee Replacement Surgery	Phase 2/Phase 3
Completed	`NCT04645550` - Apixaban, Warfarin and Aspirin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy（ESAWAAPT）	Phase 4
Recruiting	`NCT02264743` - Oral Verses Patch Trial In Menopausal Women - Individualisation of Oestrogen Therapy	Phase 4
Completed	`NCT01482273` - Ultrasound-enhanced Thrombolysis Versus Standard Catheter Directed Thrombolysis for Ilio-femoral Deep Vein Thrombosis	N/A
Recruiting	`NCT01252420` - Two Weeks of Low Molecular Weight Heparin for Distal Vein Thrombosis	Phase 4
Completed	`NCT01145859` - Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects	Phase 1